Pfeiffenberger Brent bought CRBP
May 19, 2026 · Form 4 insider transaction
Pfeiffenberger Brent bought 24,700 shares of Corbus Pharmaceuticals Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,700
Price
$0.00
Total value
N/A
InsiderPfeiffenberger Brent
RoleOfficer, Director
SecurityStock options (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 19, 2026
Filing dateMay 21, 2026
Shares owned after24,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service to the Company through each applicable vesting date.